Prognostic Stage 2 Breast Cancer AJCC v8 Recruiting Phase 1 / 2 Trials for Tucatinib (DB11652)

Also known as: Prognostic Stage II Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0140767 (Prognostic Stage 2 Breast Cancer AJCC v8)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05319873Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast CancerTreatment